Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
Is Healthcare Cybersecurity Now About Patient Safety?
Tech & Innovation Is Healthcare Cybersecurity Now About Patient Safety?

A ransomware attack on a hospital is no longer a distant headline; it is a direct and immediate threat that can grind patient care to a halt, forcing emergency rooms to divert ambulances, postponing critical surgeries, and severing access to vital medical records. The conversation surrounding

Healthcare Sees Surge in Mergers and AI Acquisitions
Tech & Innovation Healthcare Sees Surge in Mergers and AI Acquisitions

An Industry in Transformation: Decoding the M&A Boom The healthcare sector is currently in the midst of a transformative wave of consolidation, marked by a significant uptick in both traditional mergers and strategic acquisitions focused on artificial intelligence. This surge reflects a dynamic

Did a Rival Lawsuit Cost Medtronic $382 Million?
Tech & Innovation Did a Rival Lawsuit Cost Medtronic $382 Million?

A federal jury has delivered a verdict that sends shockwaves not just through the medical device industry but across the landscape of corporate competition, handing down a penalty worth over a third of a billion dollars not for a faulty product but for the way it was sold. This case highlights how

Hospital Inflation Shifts From Drugs to Tech Costs
Management & Administration Hospital Inflation Shifts From Drugs to Tech Costs

A significant transformation is underway within the financial corridors of American hospitals, as the primary drivers of supply chain inflation are pivoting away from the long-standing concern of pharmaceutical prices toward the rapidly escalating costs of technology and purchased services. A

Are Processed Foods a Danger for Cancer Survivors?
Clinical & Pharma Are Processed Foods a Danger for Cancer Survivors?

For the ever-expanding community of individuals navigating life after a cancer diagnosis, dietary choices have long been recognized as a cornerstone of maintaining long-term health and mitigating the risk of recurrence. While conventional wisdom has traditionally emphasized the balance of

Funding Cuts Threaten Breakthrough Breast Cancer Research
Clinical & Pharma Funding Cuts Threaten Breakthrough Breast Cancer Research

In a laboratory at Harvard Medical School, rows of pink-lidded jars hold not just donated breast tissue samples, but the potential to prevent a disease that will affect one in eight American women. For years, this lab, led by renowned cancer researcher Dr. Joan Brugge, has been meticulously working

Plexis Sets AI Guardrails for Healthcare Payers
Management & Administration Plexis Sets AI Guardrails for Healthcare Payers

As the healthcare industry rapidly embraces the transformative potential of artificial intelligence, a critical question emerges regarding the balance between innovation and the unwavering need for accuracy and compliance. In response to this industry-wide dialogue, PLEXIS Healthcare Systems has

What Is the Human Cost of a Weak Supply Chain?
Management & Administration What Is the Human Cost of a Weak Supply Chain?

A fragile medical supply chain is far more than a logistical challenge or a business inconvenience; it is a direct and profound threat to human health, where the consequences are not measured in dollars but in delayed treatments and compromised care. When the intricate network responsible for

NY Hospitals Avert Billion-Dollar Funding Cut
Management & Administration NY Hospitals Avert Billion-Dollar Funding Cut

New York's healthcare system has narrowly sidestepped a catastrophic financial cliff, securing a critical nine-month extension for a vital funding mechanism that will prevent an estimated billion-dollar shortfall for hospitals and nursing homes. This crucial reprieve, which pushes a looming

Can This Merger Create Lifelong Mental Healthcare?
Tech & Innovation Can This Merger Create Lifelong Mental Healthcare?

A significant career change often brings excitement and opportunity, but for millions of Americans, it also triggers a silent crisis: the loss of their trusted therapist. In a healthcare system where mental health benefits are frequently tied to employment, life transitions like a new job or a

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later